117 related articles for article (PubMed ID: 5351142)
1. [Cytogenetic studies in patients with thyroiditis and LATS and antibody-positive hyperthyroidism].
Tolksdorf M; Schemmel K; Mühlenstedt D; Uthgenannt H; Müller W
Schweiz Med Wochenschr; 1969 Jul; 99(30):1082-5. PubMed ID: 5351142
[No Abstract] [Full Text] [Related]
2. Immunoglobulin levels and long-acting thyroid stimulator (LATS) in hyperthyroidism. A preliminary study.
Yamakido M; Yokoyama M; Noguchi S
Hawaii Med J; 1969; 29(2):118-9. PubMed ID: 5361480
[No Abstract] [Full Text] [Related]
3. [Studies on the problem of a relationship between the occurrence of thyroid antibodies and LATS in hyperthyreosis].
Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
Med Klin; 1966 Dec; 61(52):2062-3. PubMed ID: 5999210
[No Abstract] [Full Text] [Related]
4. Transient thyrotoxicosis in an infant delivered to a long-acting thyroid stimulator (LATS)- and LATS protector-negative, thyroid-stimulating antibody-positive woman with Hashimoto's thyroiditis.
Hoffman WH; Sahasrananan P; Ferandos SS; Burek CL; Rose NR
J Clin Endocrinol Metab; 1982 Feb; 54(2):354-6. PubMed ID: 6119322
[TBL] [Abstract][Full Text] [Related]
5. [Long-acting thyroid stimulator (LATS) in thyroid gland diseases and its relationship to the thyroid gland antibodies].
Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
Schweiz Med Wochenschr; 1967 Jul; 97(28):898-904. PubMed ID: 5587446
[No Abstract] [Full Text] [Related]
6. [LATS and thyroid antibody level in the blood in Basedow's disease].
Földes J; Takó J; Bános C; Gesztesi E; Varga I
Orv Hetil; 1968 Aug; 109(33):1799-804. PubMed ID: 5714825
[No Abstract] [Full Text] [Related]
7. [Immunological problems in thyroid diseases].
Müller W
Med Klin; 1969 Aug; 64(34):1487-92. PubMed ID: 4900624
[No Abstract] [Full Text] [Related]
8. Specific and nonspecific responses in the bioassay of long-acting thyroid stimulator (LATS).
Chopra IJ; Solomon DH; Limberg NP
J Clin Endocrinol Metab; 1970 Oct; 31(4):382-90. PubMed ID: 5468701
[No Abstract] [Full Text] [Related]
9. [Parallel study of the thyrostimulating factor with prolonged action (LATS) and of circulating anti-thyroglobulin antibodies. Preliminary results].
Liberti P; De Santis R; Grasso L; Martino E; Pinchera A; Baschieri L
Folia Endocrinol; 1966 Dec; 19(6):659-66. PubMed ID: 6014021
[No Abstract] [Full Text] [Related]
10. Two sisters, one with Graves' disease and the second with thyroiditis and transient hyperthyroidism.
Tong A; Farid NR; Stenszky V
Acta Med Acad Sci Hung; 1982; 39(1-2):7-10. PubMed ID: 6897475
[No Abstract] [Full Text] [Related]
11. [Relation between Basedow's disease and Hashimoto thyroiditis].
Földes J; Takó J; Bános C; Gesztesi E; Juhász J
Endokrinologie; 1971 Apr; 57(3):329-37. PubMed ID: 5108742
[No Abstract] [Full Text] [Related]
12. Long-acting thyroid stimulator (LATS) in hyperthyroidism and exophthalmos.
Friis T
Dan Med Bull; 1969 Nov; 16(10):294-304. PubMed ID: 5392781
[No Abstract] [Full Text] [Related]
13. Long-acting thyroid stimulator (LATS) and immunofluorescent studies in patients with pretibial myxoedema.
From E; Diederichsen H; Heydenreich G; Nielsen OS
Dan Med Bull; 1973 Dec; 20(6):188-91. PubMed ID: 4591336
[No Abstract] [Full Text] [Related]
14. [The long acting thyroid stimulator (LATS) in some thyroid diseases. Preliminary results].
Busnardo B; Accordi F; Debiasi S
Acta Isot (Padova); 1968 Oct; 8(2):165-79. PubMed ID: 5761578
[No Abstract] [Full Text] [Related]
15. Long-acting thyroid stimulator in euthyroid relatives of thyrotoxic patients.
Wall JR; Good BF; Hetzel BS
Lancet; 1969 Nov; 2(7629):1024-6. PubMed ID: 4187540
[No Abstract] [Full Text] [Related]
16. [Studies on "cellular antibodies" against thyroid gland antigens in immunothyroiditis and hyperthyroidism].
Helmke K; Böhm W; Federlin K
Verh Dtsch Ges Inn Med; 1971; 77():1129-33. PubMed ID: 4949689
[No Abstract] [Full Text] [Related]
17. Long-acting thyroid stimulator (LATS) and long acting thyroid stimulator protector (LATS-P) in untreated thyrotoxicosis.
Hardisty CA; Hanford L; Humphries H; Munro DS
Clin Endocrinol (Oxf); 1981 Jun; 14(6):631-9. PubMed ID: 6895353
[TBL] [Abstract][Full Text] [Related]
18. Relationship of long-acting thyroid stimulator to pretibial myxedema.
Schermer DR; Roenigk HH; Schumacher OP; McKenzie JM
Arch Dermatol; 1970 Jul; 102(1):62-7. PubMed ID: 4925011
[No Abstract] [Full Text] [Related]
19. [TSH and the "long-acting thyroid stimulator" (LATS) in patients with compensated hyperthyroidism].
zur Mühlen A von ; Hesch RD; von Lilienfeld H; Emrich D
Acta Endocrinol Suppl (Copenh); 1971; 152():86. PubMed ID: 5313711
[No Abstract] [Full Text] [Related]
20. [Clinical studies on hyperthyroidism with special references to clinical-statistical surveys and studies on 131-I-triiodothyronine resin sponge uptake test and long-acting thyroid stimulator (LATS)].
Hayashida M
Sapporo Igaku Zasshi; 1966 Dec; 30(6):292-320. PubMed ID: 6010790
[No Abstract] [Full Text] [Related]
[Next] [New Search]
